The Centers for Disease Control held a webcast meeting today to announce the release of their “Updated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010 Season” (see http://www.flu.gov/vaccine/antiviralguidance.html). The purpose of these interim regulations was to
Read the rest of this entry
BioCryst (BCRX) has filed for two Phase III clinical trials for peramivir,
Read the rest of this entry


